HC Wainwright & Co. analyst Ed Arce downgrades Iterum Therapeutics (NASDAQ:ITRM) from Buy to Neutral.
Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation And Transitions BNP Business To Beckman Coulter; Co. To Receive Cash Payments $70M-$75M Per Year Through 2029
Settlement Agreement ends litigation that began in November 2017, following Quidel's acquisition of the BNP Business from Alere, Inc. ("Alere")
Quidel to receive cash payments between $70
